» Articles » PMID: 29054188

Effect of Thrombolytic Therapy on the Patterns of Post Myocardial Infarction Ventricular Septal Rupture

Overview
Journal Indian Heart J
Publisher Elsevier
Date 2017 Oct 22
PMID 29054188
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Ventricular septal rupture (VSR) is a rare but feared complication after myocardial infarction (MI). The objective of this study was to investigate the effects of thrombolytic therapy on the patterns of VSR following MI.

Methods: 30 consecutive patients admitted to a single tertiary level cardiac hospital with a diagnosis of acute MI and developed VSR in the hospital were included. The effect on thrombolytic therapy on the formation of VSR and its clinical outcome was studied.

Results: Out of 30 patients, 15 patients received thrombolytic therapy.10 received early (<12h) and 5 received late (>12h). The median time to post MI VSR formation was significantly shorter in thrombolysis group compared to non thrombolysis group at 1 vs 3 days(p=0.026). The median time for VSR formation was shorter in early thrombolysis group compared to late thrombolysis group at 1 vs 3 days (p=0.022). There was no difference between late and no thrombolytic therapy (3 vs 3 days, p=0.672). There was no significant difference in the mortality between thrombolytic and no thrombolytic therapy (p=0.690). Patients treated medically had a significant higher mortality compared to patients treated surgically (p=0.005).

Conclusion: Thrombolytic therapy results in an earlier presentation of VSR after MI. This earlier presentation may be due to reduction in the number of patients developing late VSR after thrombolytic therapy, while the number of patients developing an early VSR remaining unaffected. Despite improvements in medical therapy and percutaneous and surgical techniques, mortality with this complication remains extremely high.

Citing Articles

Study of mechanical complications in patients with acute ST-segment elevated myocardial infarction.

Mathur R, Lakhawat V, Kesarwani V, Sarda P, Baroopal A Indian Heart J. 2024; 76(1):60-62.

PMID: 38301960 PMC: 10943558. DOI: 10.1016/j.ihj.2024.01.015.


Ventricular Septal Rupture Management in Patients With Acute Myocardial Infarction: A Review.

Tripathi A, Bisht H, Arya A, Konat A, Patel D, Patel J Cureus. 2023; 15(6):e40390.

PMID: 37456418 PMC: 10345166. DOI: 10.7759/cureus.40390.


Optimal Time Repair of Ventricular Septal Rupture Post Myocardial Infarction.

Shafiei I, Jannati F, Jannati M J Saudi Heart Assoc. 2020; 32(2):288-294.

PMID: 33154931 PMC: 7640570. DOI: 10.37616/2212-5043.1120.


Early thrombolysis is associated with decreased operative mortality in postinfarction ventricular septal rupture.

Dogra N, Puri G, Thingnam S, Arya V, Kumar B, Mahajan S Indian Heart J. 2019; 71(3):224-228.

PMID: 31543194 PMC: 6796617. DOI: 10.1016/j.ihj.2019.04.011.

References
1.
Menon V, WEBB J, Hillis L, Sleeper L, Abboud R, Dzavik V . Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?. J Am Coll Cardiol. 2000; 36(3 Suppl A):1110-6. DOI: 10.1016/s0735-1097(00)00878-0. View

2.
Gertz S, Kragel A, Kalan J, Braunwald E, Roberts W . Comparison of coronary and myocardial morphologic findings in patients with and without thrombolytic therapy during fatal first acute myocardial infarction. The TIMI Investigators. Am J Cardiol. 1990; 66(12):904-9. DOI: 10.1016/0002-9149(90)90923-o. View

3.
Moore C, Nygaard T, Kaiser D, Cooper A, Gibson R . Postinfarction ventricular septal rupture: the importance of location of infarction and right ventricular function in determining survival. Circulation. 1986; 74(1):45-55. DOI: 10.1161/01.cir.74.1.45. View

4.
Crenshaw B, Granger C, Birnbaum Y, Pieper K, Morris D, Kleiman N . Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation. 2000; 101(1):27-32. DOI: 10.1161/01.cir.101.1.27. View

5.
Farb A, Kolodgie F, Jenkins M, Virmani R . Myocardial infarct extension during reperfusion after coronary artery occlusion: pathologic evidence. J Am Coll Cardiol. 1993; 21(5):1245-53. DOI: 10.1016/0735-1097(93)90253-w. View